2021
DOI: 10.3390/brainsci11091113
|View full text |Cite
|
Sign up to set email alerts
|

Survival in the Three Common Variants of Primary Progressive Aphasia: A Retrospective Study in a Tertiary Memory Clinic

Abstract: Knowledge on the natural history of the three main variants of primary progressive aphasia (PPA) is lacking, particularly regarding mortality. Moreover, advanced stages and end of life issues are rarely discussed with caregivers and families at diagnosis, which can cause more psychological distress. We analyzed data from 83 deceased patients with a diagnosis of PPA. We studied survival in patients with a diagnosis of logopenic variant (lvPPA), semantic variant (svPPA), or non-fluent variant (nfvPPA) and examin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
11
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1
1

Relationship

2
8

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 26 publications
2
11
0
1
Order By: Relevance
“…As to the median survival of PPA-MND patients – i.e., ≈3 years –, it was slightly lower than that of patients with PPA only ( Montembeault et al, 2018 ), this agreeing with the fact that MN involvement represents a risk factor for a shorter survival in PPA patients ( De La Sablonnière et al, 2021 ; El-Wahsh et al, 2021 ). Its high heterogeneity herewith found might be accounted for by the diversities across both PPA and MND phenotypes – since survival is longer in SD than in PNFA ( Tastevin et al, 2021 ), and shorter in classical ALS as compared to atypical MND variants – such as predominant-UMN phenotypes ( Turner and Talbot, 2020 ), which were relatively highly represented (25.5%) among PPA-MND patients.…”
Section: Discussionmentioning
confidence: 85%
“…As to the median survival of PPA-MND patients – i.e., ≈3 years –, it was slightly lower than that of patients with PPA only ( Montembeault et al, 2018 ), this agreeing with the fact that MN involvement represents a risk factor for a shorter survival in PPA patients ( De La Sablonnière et al, 2021 ; El-Wahsh et al, 2021 ). Its high heterogeneity herewith found might be accounted for by the diversities across both PPA and MND phenotypes – since survival is longer in SD than in PNFA ( Tastevin et al, 2021 ), and shorter in classical ALS as compared to atypical MND variants – such as predominant-UMN phenotypes ( Turner and Talbot, 2020 ), which were relatively highly represented (25.5%) among PPA-MND patients.…”
Section: Discussionmentioning
confidence: 85%
“…In this special issue, our group has provided recent insights into survival in the three PPAs. Indeed, significant differences in survival were found with svPPA showing the longest and nfvPPA showing more neurologically-related causes of death [70].…”
Section: Survival Datamentioning
confidence: 99%
“…Notably, sv-PPA patients attended more clinical visits and sv-PPA carers completed more CBI-R questionnaires than their PPA variant counterparts. Although the varying rates of attrition may reflect each variant's trajectory to incapacity and death (Tastevin et al, 2021), we acknowledge that these high and varying rates of nonparticipation at follow up visit (and completion of behavioural measures) likely contributed to the data modelling. Accordingly, more research is needed using larger groups with higher participation rates to verify our findings.…”
Section: Discussionmentioning
confidence: 99%